THE EFFECTIVENESS OF HYDROLYZED VCO CREAM ON VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION AND COLLAGEN THICKNESS FOR HEALING 2ND DEGREE BURNS INJURY IN WISTAR RATS
DOI:
https://doi.org/10.36408/mhjcm.v8i3.561Keywords:
hydrolyzed VCO, Second-degree burns, VEGF, Thickening of Collagen, Healing of burns in ratsAbstract
ABSTRACT
Burn wounds remain a serious problem in several countries. The presence of burn wounds might trigger local or in severe cases also triggers systemic response. Immediate treatment is required to prevent further tissue damage. Silver sulfadiazine cream is commonly used as a burn therapy. However, long-time usage might cause negative side effects. Several effective alternatives with better safety are opted, including virgin coconut oil (VCO). Originating from Cocos nucifera, commonly known as the coconut plant, VCO is a product that contains a lot of beneficial substances, such as lauric acid, polyphenol, and alpha-tocopherol. Hydrolyzed VCO can be an alternative to topical drugs in second-degree burns as it increases Vascular Endothelial Growth Factor (VEGF) expression and collagen thickness in the burn wound healing phase.
This randomized post-test only with parallel-group experiment was done using Wistar rats induced to a second-degree burn. The effect of 70% and 100% on second-degree burn healing, measured by hydrolyzed VCO on VEGF expression and collagen thickness was observed between 6 and 12 days of therapy. VEGF expression and collagen expression increased higher in groups treated with 70% and 100% hydrolyzed VCO compared with the control group treated with base cream.
Downloads
References
REFERENCES
Sjamsuhidajat R, Jong WD: Buku ajar ilmu bedah Samsuhidajat-De Jong. 4th Edition. Jakarta: EGC. 2014.
Shehan H, Peter D: ABC of burns :Pathophysiology and types of burns. BMJ 328(7453):1427 – 9, 2004.
Garcia-Espinoza, Aguilar-Aragon, Ortiz-Villalobos, Garcia-Manzano RA and Antonio BA: Burns: Definition, Classification, Pathophysiology and Initial Approach. Los Angeles : Gen Med. 5 : 5, 2017.
Departement of Information Evidence and Research. WHO methods and data sources for global burden of disease estimates 2000-2016. Geneva; 2018.
Garcia-Espinoza, Aguilar-Aragon, Ortiz-Villalobos, Garcia-Manzano RA and Antonio BA: Burns: Definition, Classification, Pathophysiology and Initial Approach. Los Angeles : Gen Med. 5 : 5, 2017.
Papini R: Management of burn injuries of various depths. BMJ 329(7458):158 – 60, 2004.
The Australian and New Zealand Burn Association Limited: Emergency Management of Severe Burns. Indonesia Kolegium Ilmu Bedah Indonesia. 2013.
Rowan MP, Cancio LC, Elster EA, Burmeister DM, Rose LF, Natesan S, et al: Burn wound healing and treatment: review and advancements. Crit Care 19:243,2015.
Qing C: The molecular biology in wound healing and non-healing wound. Chin J Traumatol 20:189 – 193, 2017.
Clauss M: Molecular biology of the VEGF and the VEGF receptor family. Semin Thromb Hemos 26:561–569, 2000.
Ruszczak Z: Effect of collagen matrices on dermal wound hesling. Adv. Drug Deliv. Rev 55(12):1595-1611, 2003.
Munire K, Ozgok K, John-Paul R: Wound Healing. United States StatPearls Publishing. 2019.
Mousavi SA, Mousavi SJ, Zamani A, Nourani SZ, Abbasi A, Nasiri E, et al: Comparison of Burn Treatment with Nano Silver-Aloe Vera Combination and Silver Sulfadiazine in Animal Models 24:3, 2019.
Manisha D, Shyamapada M: Coconut (Cocos nucifera L. : Arecaceae) : In health promotion and disease prevention. . Asian Pac J Trop Med 4(3):241 – 7, 2011.
Lima EBC, Sousa CNS, Meneses LN, Ximenes NC, A. SJM, Vasconcelos GS, et al: Cocos nucifera (L.) (Arecaceae) : A phytochemical and pharmacological review. Braz J Med Biol Res 48(11): 953 – 64, 2015.
Christina B, Wilma B, Donald B, Curtis K, James MJ, Ronald S, et al: Final Report on the Safety Assessment of Cocos nucifera (Coconut) Oil and Related Ingredients. Int J Toxicol 30:5S-16S, 2011.
Silalahi J, Surbakti C: Burn wound healing activity of hydrolyzed virgin coconut oil. IntJ PharmTech Res 8(1):67 -73, 2015.
Yade P, Silalahi J, Putra EDL: Antibacterial activity of hydrolyzed virgin coconut oil. Asian J Pharm and Clin Res 7:90-4, 2014.
Nguyen VTA, Le TD, Phan HN, Tran LB: Antibacterial activity of free fatty acids from hydrolyzed virgin coconut oil using lipase from candida rugosa. J Lipids 2017: 1-7, 2017.
Ibrahim AH, Li H, Al-Rawi SS, Majid ASA, Al-Habib OA, Xia X, et al: Angiogenic and wound healing potency of fermented virgin coconut oil: in vitro and in vivo studies. Am J Transl Res 9:4936-44, 2017.
Gonzalez AC CT, Andrade ZA, Medrado AR: Wound healing - A literature review. An Bras Dermatol 91(5):614 – 20, 2016.
Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM: Wound healing : Immunological aspects. Injury, Int J Care Injured 37S:S5—S12, 2006.
Thiruvoth FM, Mohapatra DP, Kumar D, Chittoria SRK, Nandhagopal V: Current concepts in the physiology of adult wound healing. Plast Aesthet Res 2:250-6, 2015.
Prasetyono TOH: General concept of wound healing, revisited. Med J Indones 18(3):208-16, 2009.
Davison KE, Marshall WS, Garcia GE: Sources of collagen for Biomaterials in skin wound healing. Bioengineering (Basel) 6 (3), 2019.
Soliman AM, Lin TS, Ghafar NA, Das S: Virgin coconut oil and diabetic wound healing: histopathological and biochemical analysis. Eur J Anat 22:135-44, 2018.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
